Regulators will continue to evaluate suicide ideation as the data don’t “definitively rule out” the danger.Dive Brief:The use of GLP-1-based drugs to treat obesity and diabetes has no “clear relationship” with the risk of suicidal thoughts or actions, the Food and Drug Administration said Thursday after completing a review of reports in its adverse events […]
